This finding is consistent with a previous study that reported an association between increased SLC6A4 promoter methylation and susceptibility to major depression.14 Furthermore, we identified significant inverse correlations between FA and AD values of the body of the corpus callosum and SLC6A4 methylation at CpG3 in patients with MDD. This evidence concerns the gene SLC6A4 and Alzheimer disease.